
After entering into a previous settlement that covered current claims, Bayer entered into a $2 billion deal that would settle any future claims related to its weedkiller Roundup. Bayer had struggled for months to reach a settlement of claims that Roundup was linked with cases of non-Hodgkin’s lymphoma, a type of cancer. Bayer inherited the […]